Myocyte Enhancer Factor 2 Acetylation by p300 Enhances Its DNA Binding Activity, Transcriptional Activity, and Myogenic Differentiation
暂无分享,去创建一个
Zhenguo Wu | Kewei Ma | G. Zhu | Zhenguo Wu | Kewei Ma | Jonathan K. L. Chan | Guang Zhu | J. Chan
[1] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[2] B. Kirschbaum,et al. A Novel Complex Regulates cardiac actin Gene Expression through Interaction of Emb, a Class VI POU Domain Protein, MEF2D, and the Histone Transacetylase p300 , 2004, Molecular and Cellular Biology.
[3] Zhenguo Wu,et al. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation , 2004, Journal of Cell Science.
[4] L. Kedes,et al. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C , 1997, Molecular and cellular biology.
[5] A. Harel-Bellan,et al. Acetylation of MyoD by p300 Requires More Than Its Histone Acetyltransferase Domain* , 2001, The Journal of Biological Chemistry.
[6] L. Kedes,et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.
[7] E. Topol,et al. Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease , 2003, Science.
[8] R A Schulz,et al. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila , 1995, Science.
[9] L. Kedes,et al. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. , 1999, Molecular cell.
[10] A. Lassar,et al. Inhibition of Myogenic bHLH and MEF2 Transcription Factors by the bHLH Protein Twist , 1996, Science.
[11] Po Zhao,et al. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. , 2003, Molecular cell.
[12] C. Bucana,et al. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.
[13] E. Olson,et al. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains , 1992, Cell.
[14] Jonas Wittwer,et al. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5 , 2003, The EMBO journal.
[15] Chun Li Zhang,et al. Signaling chromatin to make muscle. , 2002, Current opinion in cell biology.
[16] Jiahuai Han,et al. Regulation of the MEF2 Family of Transcription Factors by p38 , 1999, Molecular and Cellular Biology.
[17] E. Olson,et al. Control of muscle development by dueling HATs and HDACs. , 2001, Current opinion in genetics & development.
[18] C. Allis,et al. Roles of histone acetyltransferases and deacetylases in gene regulation , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[19] G. Zhu,et al. Functional Characterization of an Amino-terminal Region of HDAC4 That Possesses MEF2 Binding and Transcriptional Repressive Activity* , 2003, Journal of Biological Chemistry.
[20] R. Schiltz,et al. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program , 2001, The EMBO journal.
[21] B. Nadal-Ginard,et al. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. , 1993, Development.
[22] E. Olson,et al. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. , 1993, Science.
[23] B. Black,et al. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor , 2002, Nature Medicine.
[24] B. Black,et al. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.
[25] H. Youn,et al. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. , 1999, Science.
[26] Qing Xu,et al. The Insulin-like Growth Factor-Phosphatidylinositol 3-Kinase-Akt Signaling Pathway Regulates Myogenin Expression in Normal Myogenic Cells but Not in Rhabdomyosarcoma-derived RD Cells* , 2000, The Journal of Biological Chemistry.
[27] M. Goebl,et al. Phosphorylation of Nuclear MyoD Is Required for Its Rapid Degradation , 1998, Molecular and Cellular Biology.
[28] B. Black,et al. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.
[29] M E Greenberg,et al. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. , 1999, Science.
[30] P. Rigby,et al. The regulation of myogenin gene expression during the embryonic development of the mouse. , 1993, Genes & development.
[31] B. Wold,et al. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. , 1996, Current opinion in cell biology.
[32] E. Olson,et al. Defining the regulatory networks for muscle development. , 1996, Current opinion in genetics & development.
[33] Wei Gu,et al. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. , 2003, Current opinion in cell biology.
[34] A. Ciechanover,et al. A novel site for ubiquitination: the N‐terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein , 1998, The EMBO journal.
[35] R. W. Lee,et al. Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. , 1992, Molecular biology of the cell.
[36] Jiahuai Han,et al. BMK1/ERK5 regulates serum‐induced early gene expression through transcription factor MEF2C , 1997, The EMBO journal.
[37] Jiahuai Han,et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation , 1997, Nature.
[38] Zhenguo Wu,et al. p38 and Extracellular Signal-Regulated Kinases Regulate the Myogenic Program at Multiple Steps , 2000, Molecular and Cellular Biology.
[39] H. Arnold,et al. The myogenin gene is activated during myocyte differentiation by pre-existing, not newly synthesized transcription factor MEF-2. , 1994, The Journal of biological chemistry.
[40] A. Giordano,et al. p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription , 1997, The EMBO journal.
[41] Jiing-Dwan Lee,et al. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. , 2004, The Journal of clinical investigation.
[42] J B Lawrence,et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.